Quarfloxin (CX-3543)

Catalog No. A12380

Quarfloxin (CX-3543)是一种具有抗肿瘤活性的氟喹诺酮衍生物。quarfloxin破坏核蛋白和核糖体dna (rdna)模板中g-四链体dna结构之间的相互作用,这是在癌细胞中过度表达的rrna生物发生的关键相互作用;这种g-四链体dna的破坏:异常rrna生物发生中的蛋白质相互作用可能导致核糖体合成和肿瘤细胞凋亡的抑制。
  • Janne J. M. van Schie, .et al. Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion, Nat Commun, 2020, 11: 4287 PMID: 32855419
  • Yue Sheng, .et al. Role of c-Myc haploinsufficiency in the maintenance of HSCs, Blood, 2020, Aug 21 PMID: 32822452
  • Hald øH, .et al. Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma, Oncogene, 2018, Dec 12 PMID: 30542116
  • Louise E. Kerry, .et al. Selective inhibition of RNA polymerase I transcription as a potential approach to treat African trypanosomiasis, PLoS Negl Trop Dis, 2017, Mar; 11(3): e0005432 PMID: 28263991
Catalog Num A12380
M. Wt 604.67
Formula C35H33FN6O3
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 865311-47-3
Synonyms CX 3543; Quarfloxacin; CX3543; CX-3543
SMILES CN1CCC[C@H]1CCNC(=O)C2=CN3C4=CC5=CC=CC=C5C=C4OC6=C3C(=CC(=C6N7CCC(C7)C8=NC=CN=C8)F)C2=O
Quarfloxin (CX-3543)是一种具有抗肿瘤活性的氟喹诺酮衍生物。quarfloxin破坏核蛋白和核糖体dna (rdna)模板中g-四链体dna结构之间的相互作用,这是在癌细胞中过度表达的rrna生物发生的关键相互作用;这种g-四链体dna的破坏:异常rrna生物发生中的蛋白质相互作用可能导致核糖体合成和肿瘤细胞凋亡的抑制。
In vitro (25°C) DMSO Warmed: 18 mg/mL (35.57 mM)
Water Insoluble
Ethanol Insoluble
In vivo 2% DMSO+30% PEG 300+dd H2O 4 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 16.54 mL 82.69 mL 165.38 mL
0.5 mM 3.31 mL 16.54 mL 33.08 mL
1 mM 1.65 mL 8.27 mL 16.54 mL
5 mM 0.33 mL 1.65 mL 3.31 mL

*The above data is based on the productmolecular weight 604.67. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.